Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-20

Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802) [Phase 3]

View source ↗

Summary

A Phase 3 study comparing ertapenem to ceftriaxone plus metronidazole for intra-abdominal infections in adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FLAGYL (Metronidazole)
  • Invanz (ertapenem)
  • Rocephin (Ceftriaxone)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Intra-abdominal Infection | Phase 3 | Status: COMPLETED